Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the musculature (HP:0003011)help
Parent Node:
expand
Abnormal skeletal muscle morphology (HP:0011805)help
..Starting node
..expand
Rhabdomyolysis (HP:0003201)help
Term ID: 3201
Name: Rhabdomyolysis
Synonym: Breakdown of skeletal muscle
Definition: Breakdown of muscle fibers that leads to the release of muscle fiber contents (myoglobin) into the bloodstream.
Comments:
Reference: HP:0003201
Genes and Diseases:
 
       Child Nodes:
........expandViral infection-induced rhabdomyolysis (HP:0003558) help
........expandAcute rhabdomyolysis (HP:0008942) help
........expandExercise-induced rhabdomyolysis (HP:0009045) help
........expandAnesthetic-induced rhabdomylosis (HP:0011439) help
........expandAlcohol-induced rhabdomyolysis (HP:0011440) help

 Sister Nodes: 
..expandAbnormal muscle fiber morphology (HP:0004303) help
..expandAbnormality of muscle size (HP:0030236) help
..expandCalcinosis (HP:0003761) help
..expandDecreased muscle mass (HP:0003199) help
..expandFatty replacement of skeletal muscle (HP:0012548) help
..expandFirm muscles (HP:0003725) help
..expandFlexion contracture (HP:0001371) help
..expandGeneralized muscular appearance from birth (HP:0003716) help
..expandIntramuscular hematoma (HP:0012233) help
..expandLevator palpebrae superioris atrophy (HP:0012241) help
..expandMuscular dystrophy (HP:0003560) help
..expandMuscular edema (HP:0100748) help
..expandMyopathy (HP:0003198) help
..expandMyositis (HP:0100614) help
..expandSkeletal muscle fibrosis (HP:0030951) help
InputHPO IDHPO termDistanceGeneGene id entrezDiseaseIdDiseaseNameDiseaseMIMConceptIDSourceTypical associationHGMD variantsClinVar variantsHGNC IDGeneMIM
 
HPO disease - gene - phenotype typical associations:
HP:0003201HP:0003201Rhabdomyolysis0ATP5F1D CL E G H513618120MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5618120CN253835OMIM1122837603150
HP:0003201HP:0003201Rhabdomyolysis0BCS1L CL E G H617124000Mitochondrial complex III deficiency124000C1852372OMIM14131020603647
HP:0003201HP:0003201Rhabdomyolysis0CACNA1S CL E G H77979102ORPHA118861397114208
HP:0003201HP:0003201Rhabdomyolysis0CPT2 CL E G H1376255110Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced255110C1833508OMIM18762330600650
HP:0003201HP:0003201Rhabdomyolysis0GABRA3 CL E G H255679102ORPHA12194077305660
HP:0003201HP:0003201Rhabdomyolysis0HADHA CL E G H3030746Apert like polydactyly syndromeORPHA17924801600890
HP:0003201HP:0003201Rhabdomyolysis0HADHA CL E G H3030609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM17924801600890
HP:0003201HP:0003201Rhabdomyolysis0HADHB CL E G H3032746Apert like polydactyly syndromeORPHA13674803143450
HP:0003201HP:0003201Rhabdomyolysis0HADHB CL E G H3032609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM13674803143450
HP:0003201HP:0003201Rhabdomyolysis0KCNJ18 CL E G H10013444479102ORPHA11139080613236
HP:0003201HP:0003201Rhabdomyolysis0LDHA CL E G H3939612933Glycogen storage disease XI612933C2752022OMIM12066535150000
HP:0003201HP:0003201Rhabdomyolysis0PGAM2 CL E G H5224261670Glycogen storage disease type X261670C0268149OMIM11748889612931
HP:0003201HP:0003201Rhabdomyolysis0PGK1 CL E G H5230300653Phosphoglycerate kinase 1 deficiency300653C1970848OMIM13468896311800
HP:0003201HP:0003201Rhabdomyolysis0POLG CL E G H5428157640Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1157640C1834846OMIM123249179174763
HP:0003201HP:0003201Rhabdomyolysis0RYR1 CL E G H6261145600Malignant hyperthermia, susceptibility to, 1145600CN031421OMIM1616410483180901
HP:0003201HP:0003201Rhabdomyolysis0SLC25A20 CL E G H788159ORPHA11971421613698
HP:0003201HP:0003201Rhabdomyolysis0SLC25A20 CL E G H788212138Carnitine acylcarnitine translocase deficiency212138C0342791OMIM11971421613698
HP:0003201HP:0003201Rhabdomyolysis0TSFM CL E G H10102610505Combined oxidative phosphorylation deficiency 3610505C1864840OMIM143412367604723
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1ATP5F1D CL E G H513618120MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5618120CN253835OMIM1122837603150
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1ATP5F1D CL E G H513618120MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5618120CN253835OMIM1122837603150
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1ATP5F1D CL E G H513618120MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5618120CN253835OMIM1122837603150
HP:0003201HP:0008942Acute rhabdomyolysis1ATP5F1D CL E G H513618120MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5618120CN253835OMIM1122837603150
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1ATP5F1D CL E G H513618120MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5618120CN253835OMIM1122837603150
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1BCS1L CL E G H617124000Mitochondrial complex III deficiency124000C1852372OMIM14131020603647
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1BCS1L CL E G H617124000Mitochondrial complex III deficiency124000C1852372OMIM14131020603647
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1BCS1L CL E G H617124000Mitochondrial complex III deficiency124000C1852372OMIM14131020603647
HP:0003201HP:0008942Acute rhabdomyolysis1BCS1L CL E G H617124000Mitochondrial complex III deficiency124000C1852372OMIM14131020603647
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1BCS1L CL E G H617124000Mitochondrial complex III deficiency124000C1852372OMIM14131020603647
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1CACNA1S CL E G H77979102ORPHA118861397114208
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1CACNA1S CL E G H77979102ORPHA118861397114208
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1CACNA1S CL E G H77979102ORPHA118861397114208
HP:0003201HP:0008942Acute rhabdomyolysis1CACNA1S CL E G H77979102ORPHA118861397114208
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1CACNA1S CL E G H77979102ORPHA118861397114208
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1CPT2 CL E G H1376255110Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced255110C1833508OMIM18762330600650
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1CPT2 CL E G H1376255110Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced255110C1833508OMIM18762330600650
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1CPT2 CL E G H1376255110Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced255110C1833508OMIM18762330600650
HP:0003201HP:0008942Acute rhabdomyolysis1CPT2 CL E G H1376255110Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced255110C1833508OMIM18762330600650
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1CPT2 CL E G H1376255110Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced255110C1833508OMIM18762330600650
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1GABRA3 CL E G H255679102ORPHA12194077305660
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1GABRA3 CL E G H255679102ORPHA12194077305660
HP:0003201HP:0008942Acute rhabdomyolysis1GABRA3 CL E G H255679102ORPHA12194077305660
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1GABRA3 CL E G H255679102ORPHA12194077305660
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1GABRA3 CL E G H255679102ORPHA12194077305660
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1HADHA CL E G H3030746Apert like polydactyly syndromeORPHA17924801600890
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1HADHA CL E G H3030746Apert like polydactyly syndromeORPHA17924801600890
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1HADHA CL E G H3030746Apert like polydactyly syndromeORPHA17924801600890
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1HADHA CL E G H3030746Apert like polydactyly syndromeORPHA17924801600890
HP:0003201HP:0008942Acute rhabdomyolysis1HADHA CL E G H3030746Apert like polydactyly syndromeORPHA17924801600890
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1HADHA CL E G H3030609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM17924801600890
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1HADHA CL E G H3030609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM17924801600890
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1HADHA CL E G H3030609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM17924801600890
HP:0003201HP:0008942Acute rhabdomyolysis1HADHA CL E G H3030609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM17924801600890
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1HADHA CL E G H3030609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM17924801600890
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1HADHB CL E G H3032746Apert like polydactyly syndromeORPHA13674803143450
HP:0003201HP:0008942Acute rhabdomyolysis1HADHB CL E G H3032746Apert like polydactyly syndromeORPHA13674803143450
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1HADHB CL E G H3032746Apert like polydactyly syndromeORPHA13674803143450
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1HADHB CL E G H3032746Apert like polydactyly syndromeORPHA13674803143450
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1HADHB CL E G H3032746Apert like polydactyly syndromeORPHA13674803143450
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1HADHB CL E G H3032609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM13674803143450
HP:0003201HP:0008942Acute rhabdomyolysis1HADHB CL E G H3032609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM13674803143450
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1HADHB CL E G H3032609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM13674803143450
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1HADHB CL E G H3032609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM13674803143450
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1HADHB CL E G H3032609015Mitochondrial trifunctional protein deficiency609015C0342786OMIM13674803143450
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1KCNJ18 CL E G H10013444479102ORPHA11139080613236
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1KCNJ18 CL E G H10013444479102ORPHA11139080613236
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1KCNJ18 CL E G H10013444479102ORPHA11139080613236
HP:0003201HP:0008942Acute rhabdomyolysis1KCNJ18 CL E G H10013444479102ORPHA11139080613236
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1KCNJ18 CL E G H10013444479102ORPHA11139080613236
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1LDHA CL E G H3939612933Glycogen storage disease XI612933C2752022OMIM12066535150000
HP:0003201HP:0008942Acute rhabdomyolysis1LDHA CL E G H3939612933Glycogen storage disease XI612933C2752022OMIM12066535150000
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1LDHA CL E G H3939612933Glycogen storage disease XI612933C2752022OMIM12066535150000
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1LDHA CL E G H3939612933Glycogen storage disease XI612933C2752022OMIM12066535150000
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1LDHA CL E G H3939612933Glycogen storage disease XI612933C2752022OMIM12066535150000
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1PGAM2 CL E G H5224261670Glycogen storage disease type X261670C0268149OMIM11748889612931
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1PGAM2 CL E G H5224261670Glycogen storage disease type X261670C0268149OMIM11748889612931
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1PGAM2 CL E G H5224261670Glycogen storage disease type X261670C0268149OMIM11748889612931
HP:0003201HP:0008942Acute rhabdomyolysis1PGAM2 CL E G H5224261670Glycogen storage disease type X261670C0268149OMIM11748889612931
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1PGAM2 CL E G H5224261670Glycogen storage disease type X261670C0268149OMIM11748889612931
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1PGK1 CL E G H5230300653Phosphoglycerate kinase 1 deficiency300653C1970848OMIM13468896311800
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1PGK1 CL E G H5230300653Phosphoglycerate kinase 1 deficiency300653C1970848OMIM13468896311800
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1PGK1 CL E G H5230300653Phosphoglycerate kinase 1 deficiency300653C1970848OMIM13468896311800
HP:0003201HP:0008942Acute rhabdomyolysis1PGK1 CL E G H5230300653Phosphoglycerate kinase 1 deficiency300653C1970848OMIM13468896311800
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1PGK1 CL E G H5230300653Phosphoglycerate kinase 1 deficiency300653C1970848OMIM13468896311800
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1POLG CL E G H5428157640Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1157640C1834846OMIM123249179174763
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1POLG CL E G H5428157640Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1157640C1834846OMIM123249179174763
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1POLG CL E G H5428157640Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1157640C1834846OMIM123249179174763
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1POLG CL E G H5428157640Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1157640C1834846OMIM123249179174763
HP:0003201HP:0008942Acute rhabdomyolysis1POLG CL E G H5428157640Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1157640C1834846OMIM123249179174763
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1RYR1 CL E G H6261145600Malignant hyperthermia, susceptibility to, 1145600CN031421OMIM1616410483180901
HP:0003201HP:0008942Acute rhabdomyolysis1RYR1 CL E G H6261145600Malignant hyperthermia, susceptibility to, 1145600CN031421OMIM1616410483180901
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1RYR1 CL E G H6261145600Malignant hyperthermia, susceptibility to, 1145600CN031421OMIM1616410483180901
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1RYR1 CL E G H6261145600Malignant hyperthermia, susceptibility to, 1145600CN031421OMIM1616410483180901
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1RYR1 CL E G H6261145600Malignant hyperthermia, susceptibility to, 1145600CN031421OMIM1616410483180901
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1SLC25A20 CL E G H788159ORPHA11971421613698
HP:0003201HP:0008942Acute rhabdomyolysis1SLC25A20 CL E G H788159ORPHA11971421613698
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1SLC25A20 CL E G H788159ORPHA11971421613698
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1SLC25A20 CL E G H788159ORPHA11971421613698
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1SLC25A20 CL E G H788159ORPHA11971421613698
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1SLC25A20 CL E G H788212138Carnitine acylcarnitine translocase deficiency212138C0342791OMIM11971421613698
HP:0003201HP:0008942Acute rhabdomyolysis1SLC25A20 CL E G H788212138Carnitine acylcarnitine translocase deficiency212138C0342791OMIM11971421613698
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1SLC25A20 CL E G H788212138Carnitine acylcarnitine translocase deficiency212138C0342791OMIM11971421613698
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1SLC25A20 CL E G H788212138Carnitine acylcarnitine translocase deficiency212138C0342791OMIM11971421613698
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1SLC25A20 CL E G H788212138Carnitine acylcarnitine translocase deficiency212138C0342791OMIM11971421613698
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1TSFM CL E G H10102610505Combined oxidative phosphorylation deficiency 3610505C1864840OMIM143412367604723
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1TSFM CL E G H10102610505Combined oxidative phosphorylation deficiency 3610505C1864840OMIM143412367604723
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1TSFM CL E G H10102610505Combined oxidative phosphorylation deficiency 3610505C1864840OMIM143412367604723
HP:0003201HP:0008942Acute rhabdomyolysis1TSFM CL E G H10102610505Combined oxidative phosphorylation deficiency 3610505C1864840OMIM143412367604723
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1TSFM CL E G H10102610505Combined oxidative phosphorylation deficiency 3610505C1864840OMIM143412367604723
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0003201HP:0003201Rhabdomyolysis0AMPD1 CL E G H270615511Muscle AMP deaminase deficiency615511C0268123OMIM0452468102770
HP:0003201HP:0003201Rhabdomyolysis0ANO5 CL E G H203859399096ORPHA0116227337608662
HP:0003201HP:0003201Rhabdomyolysis0ISCU CL E G H23479255125Myopathy with lactic acidosis, hereditary255125C1850718OMIM016029882611911
HP:0003201HP:0003201Rhabdomyolysis0PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM04138905171900
HP:0003201HP:0003201Rhabdomyolysis0SLC12A3 CL E G H6559263800Familial hypokalemia-hypomagnesemia263800C0268450OMIM0128310912600968
HP:0003201HP:0003201Rhabdomyolysis0XK CL E G H7504300842McLeod neuroacanthocytosis syndrome300842C0398568OMIM021812811314850
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1AMPD1 CL E G H270615511Muscle AMP deaminase deficiency615511C0268123OMIM0452468102770
HP:0003201HP:0008942Acute rhabdomyolysis1AMPD1 CL E G H270615511Muscle AMP deaminase deficiency615511C0268123OMIM0452468102770
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1AMPD1 CL E G H270615511Muscle AMP deaminase deficiency615511C0268123OMIM0452468102770
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1AMPD1 CL E G H270615511Muscle AMP deaminase deficiency615511C0268123OMIM0452468102770
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1AMPD1 CL E G H270615511Muscle AMP deaminase deficiency615511C0268123OMIM0452468102770
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1ANO5 CL E G H203859399096ORPHA0116227337608662
HP:0003201HP:0008942Acute rhabdomyolysis1ANO5 CL E G H203859399096ORPHA0116227337608662
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1ANO5 CL E G H203859399096ORPHA0116227337608662
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1ANO5 CL E G H203859399096ORPHA0116227337608662
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1ANO5 CL E G H203859399096ORPHA0116227337608662
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1ISCU CL E G H23479255125Myopathy with lactic acidosis, hereditary255125C1850718OMIM016029882611911
HP:0003201HP:0008942Acute rhabdomyolysis1ISCU CL E G H23479255125Myopathy with lactic acidosis, hereditary255125C1850718OMIM016029882611911
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1ISCU CL E G H23479255125Myopathy with lactic acidosis, hereditary255125C1850718OMIM016029882611911
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1ISCU CL E G H23479255125Myopathy with lactic acidosis, hereditary255125C1850718OMIM016029882611911
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1ISCU CL E G H23479255125Myopathy with lactic acidosis, hereditary255125C1850718OMIM016029882611911
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM04138905171900
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM04138905171900
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM04138905171900
HP:0003201HP:0008942Acute rhabdomyolysis1PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM04138905171900
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1PGM1 CL E G H5236614921Congenital disorder of glycosylation type 1t614921C2752015OMIM04138905171900
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1SLC12A3 CL E G H6559263800Familial hypokalemia-hypomagnesemia263800C0268450OMIM0128310912600968
HP:0003201HP:0008942Acute rhabdomyolysis1SLC12A3 CL E G H6559263800Familial hypokalemia-hypomagnesemia263800C0268450OMIM0128310912600968
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1SLC12A3 CL E G H6559263800Familial hypokalemia-hypomagnesemia263800C0268450OMIM0128310912600968
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1SLC12A3 CL E G H6559263800Familial hypokalemia-hypomagnesemia263800C0268450OMIM0128310912600968
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1SLC12A3 CL E G H6559263800Familial hypokalemia-hypomagnesemia263800C0268450OMIM0128310912600968
HP:0003201HP:0011440Alcohol-induced rhabdomyolysis1XK CL E G H7504300842McLeod neuroacanthocytosis syndrome300842C0398568OMIM021812811314850
HP:0003201HP:0008942Acute rhabdomyolysis1XK CL E G H7504300842McLeod neuroacanthocytosis syndrome300842C0398568OMIM021812811314850
HP:0003201HP:0003558Viral infection-induced rhabdomyolysis1XK CL E G H7504300842McLeod neuroacanthocytosis syndrome300842C0398568OMIM021812811314850
HP:0003201HP:0009045Exercise-induced rhabdomyolysis1XK CL E G H7504300842McLeod neuroacanthocytosis syndrome300842C0398568OMIM021812811314850
HP:0003201HP:0011439Anesthetic-induced rhabdomylosis1XK CL E G H7504300842McLeod neuroacanthocytosis syndrome300842C0398568OMIM021812811314850


Genes (28) :ACADL ACADVL AMPD1 ANO5 ATP5F1D BCS1L CACNA1S CPT2 CTDP1 DGUOK GABRA3 HADHA HADHB ISCU KCNJ18 LDHA LPIN1 PGAM2 PGK1 PGM1 POLG PYGM RYR1 SLC12A3 SLC25A20 TANGO2 TSFM XK

Diseases (29) :615511 399096 618120 124000 79102 255110 746 609015 255125 612933 261670 300653 614921 157640 145600 263800 159 212138 610505 300842 99900 201475 423 48431 604168 329314 268200 232600 616878
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is August 2021 release.